3MColgate-Palmolive

3M vs Colgate-Palmolive

Global industrial conglomerate spanning safety consumer and healthcare products vs Global oral care and household products leader. Which is the better buy for your portfolio in July 2026? Plain-English answer below.

3M generates revenues across industrial, safety, and health care segments with a patent portfolio that took decades to build, while Colgate-Palmolive wrings growth from toothpaste, pet nutrition, and ...

Why It’s Moving

3M

3M is trading on analyst caution and sector sentiment, not a fresh catalyst.

  • Analyst views on 3M remain mixed but generally steady, with consensus ratings clustering around Hold even as some models lean more constructive; that suggests the market is still waiting for a clearer catalyst before re-rating the stock.
  • Recent price-target estimates vary widely across research firms, implying uncertainty around how quickly 3M can convert operational improvements into sustained upside.
  • With no major company-specific news in the last week, MMM is being driven more by broader industrial-sector sentiment and investor focus on execution, margins, and litigation-related overhangs than by fresh headlines.
Sentiment:
⚖️Neutral
Colgate-Palmolive

Colgate-Palmolive is under pressure as valuation worries outweigh its steady growth story.

  • Analysts are flagging Colgate-Palmolive as expensive after a long rally, arguing the stock’s valuation now leaves less room for upside and more room for disappointment.
  • The bearish case centers on growth that has been driven more by price increases than by higher product volume, which raises questions about how durable the company’s momentum really is.
  • Margin gains may be nearing a peak, and in a higher-rate market, the stock’s low dividend yield looks less compelling versus its valuation, adding to downside risk concerns.
Sentiment:
🐻Bearish

Investment Analysis

3M

3M

MMM

Pros

  • 3M has raised its 2025 earnings outlook, reflecting improved profitability and successful execution of its turnaround strategy.
  • The company has delivered strong organic sales growth and expanded operating margins, driven by cost controls and a shift towards higher-margin products.
  • Recent settlements of long-standing legal issues have reduced uncertainty and cleared the path for future growth and investment.

Considerations

  • Despite recent gains, 3M's valuation scores only moderately on undervaluation metrics, suggesting limited upside potential for new investors.
  • The stock has experienced significant volatility, with technical forecasts indicating possible downward pressure in the near term.
  • Ongoing restructuring and product mix changes carry execution risks that could affect future performance.

Pros

  • Colgate-Palmolive maintains a strong global brand presence and consistent demand for its consumer products across multiple categories.
  • The company operates with a stable balance sheet and a history of reliable dividend payments, appealing to income-focused investors.
  • Colgate-Palmolive benefits from a diversified product portfolio, including oral care, personal care, and pet nutrition segments.

Considerations

  • Revenue growth has been relatively slow, constrained by mature markets and limited pricing power in key regions.
  • The company faces increasing competition from private labels and new entrants in the consumer goods sector.
  • Exposure to foreign exchange fluctuations and input cost volatility can impact profitability.

3M (MMM) Next Earnings Date

3M (MMM) is expected to report its next earnings on July 27, 2026. This release should cover Q2 2026 results, based on the company’s projected earnings calendar. Some market data services had earlier estimated July 17, 2026, but the more recent projected calendar points to July 27, 2026.

Colgate-Palmolive (CL) Next Earnings Date

Colgate-Palmolive (CL) is expected to report next on July 31, 2026, with some sources listing August 7, 2026 as an alternative estimate. The upcoming release should cover Q2 2026 results. The most commonly cited schedule points to a late-July announcement before the market opens.

Buy MMM or CL in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

MMM
MMM$181.41
vs
CL
CL$93.60
Buy MMM